Diabetes Research and Clinical Practice - Volume 106 - Supplement 1 - November 2014 - page 6

Diabetes Research and Clinical Practice 106S1 (2014) v–vi
Contents
available
at
ScienceDirect
Diabetes
Research
and
Clinical
Practice
journal
homepage:
Contents
Oral presentation abstracts
S1
Behavioural interventions and management tools ...............................................................................
S1
Therapeutics – oral and novel agents ................................................................................................
S3
Diabetes in different communities ...................................................................................................
S6
Nephropathy – basic & experimental science ......................................................................................
S8
Microvascular complications ..........................................................................................................
S10
Clinical diabetes ..........................................................................................................................
S13
Macrovascular disease ..................................................................................................................
S16
Metabolic regulation .....................................................................................................................
S18
Therapeutics – oral agents .............................................................................................................
S20
Cost-effective health care and outcomes ...........................................................................................
S24
Genetics ....................................................................................................................................
S26
Nephropathy – clinical & translational research ..................................................................................
S29
Obesity and metabolic syndrome .....................................................................................................
S31
Nutrition & diabetes .....................................................................................................................
S34
Insulin treatment and islet cell signalling ..........................................................................................
S36
Insulin resistance .........................................................................................................................
S39
Presidential Posters
S42
Islet cell signalling and biology ........................................................................................................
S42
Oral agents .................................................................................................................................
S42
Other ........................................................................................................................................
S43
Posters
S47
Cardiovascular disease, atherosclerotic disease, diabetic foot .................................................................
S47
Clinical nutrition .........................................................................................................................
S66
Diabetes and exercise ...................................................................................................................
S72
DM in pregnancy ..........................................................................................................................
S75
Education ...................................................................................................................................
S80
Genetics of type 1/2 diabetes ..........................................................................................................
S87
Glucose monitoring and sensing / diabetes technology ..........................................................................
S89
Healthcare delivery ......................................................................................................................
S92
Hypoglycaemia ............................................................................................................................
S104
Immunology ...............................................................................................................................
S113
Insulin action ..............................................................................................................................
S114
1,2,3,4,5 7,8,9,10,11,12,13,14,15,16,...288